Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Myocardial Infarction”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Not applicableStudy completedNCT00031213
What this trial is testing

Heavy Metals, Obesity and Cardiovascular Risk - Ancillary to Look AHEAD

Who this might be right for
Diabetes Mellitus, Non-insulin DependentCardiovascular DiseasesObesity+3 more
National Heart, Lung, and Blood Institute (NHLBI)
Post-approval studies (Phase 4)Study completedNCT00627744
What this trial is testing

Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction

Who this might be right for
Myocardial InfarctionUnstable Angina PectorisDiabetes Mellitus+1 more
Karolinska Institutet 85
Not applicableStudy completedNCT03953651
What this trial is testing

Clinical Presentation and Outcomes in Patients at Risk of Type II Myocardial InfarctioN in the emerGency Department.

Who this might be right for
Myocardial Oxygenation ImbalanceMyocardial Infarction
Hospices Civils de Lyon 1,000
Post-approval studies (Phase 4)Study completedNCT01107886
What this trial is testing

Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 18,206
Not applicableStudy completedNCT00782366
What this trial is testing

Predictive Genetic Risk Assessment Trial

Who this might be right for
Colon CancerLung CancerAtrial Fibrillation+8 more
Mayo Clinic 26
Not applicableStudy completedNCT05053828
What this trial is testing

Type 2 Diabetes With Antiplatelet Drugs

Who this might be right for
Type2 DiabetesAntiplatelet DrugsMyocardial Infarction+1 more
Tabula Rasa HealthCare 173,464
Testing effectiveness (Phase 2)Active Not RecruitingNCT06186102
What this trial is testing

Polyamine Treatment in Elderly Patients With Coronary Artery Disease

Who this might be right for
Ischemic Heart DiseaseMyocardial InfarctionCardiovascular Diseases+11 more
University of Aarhus 180
Not applicableStudy completedNCT03648424
What this trial is testing

Prediction of Findings From the Ongoing CAROLINA Trial Using Healthcare Database Analyses

Who this might be right for
Type 2 Diabetes Mellitus
Brigham and Women's Hospital 48,262
Large-scale testing (Phase 3)UnknownNCT03658031
What this trial is testing

Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction

Who this might be right for
PreDiabetesMyocardial InfarctionT2DM (Type 2 Diabetes Mellitus)+1 more
Hamad Medical Corporation 576
Not applicableActive Not RecruitingNCT07123480
What this trial is testing

The Role of 4 Different Consent Approaches on a Pilot Study to Increase Cardiac Rehabilitation Attendance

Who this might be right for
EthicsCardiac RehabilitationCoronary Heart Disease (CHD)+4 more
Baystate Medical Center 160
Not applicableStudy completedNCT06845956
What this trial is testing

Prevalence, Clinical Features, and Prognosis of Coronary Artery Embolism With Concomitant Atrial Fibrillation

Who this might be right for
Coronary Artery EmbolismAcute Myocardial Infarction Type 2
First Affiliated Hospital of Ningbo University 5,163
Not applicableActive Not RecruitingNCT07198191
What this trial is testing

SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study

Who this might be right for
Acute Myocardial Infarction (AMI)Type 2 Diabetes Mellitus (T2DM)
Yonsei University 200,000
Post-approval studies (Phase 4)Study completedNCT03329261
What this trial is testing

Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg

Who this might be right for
Diabetes Mellitus, Type 2NSTEMI - Non-ST Segment Elevation MICoronary Angioplasty
Laboratoires Teriak 167
Not applicableStudy completedNCT04864119
What this trial is testing

DEFINing the PrEvalence and Characteristics of Coronary Artery Disease Among Patients With TYPE 2 Myocardial Infarction Using CT-FFR

Who this might be right for
Type 2 Myocardial Infarction
Massachusetts General Hospital 50
Not applicableNot Yet RecruitingNCT05793567
What this trial is testing

Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)

Who this might be right for
Myocardial InfarctionCoronary Microvascular Disease
Mayo Clinic 52
Not applicableActive Not RecruitingNCT00005487
What this trial is testing

Multi-Ethnic Study of Atherosclerosis (MESA)

Who this might be right for
AtherosclerosisCardiovascular DiseasesHeart Diseases+8 more
National Heart, Lung, and Blood Institute (NHLBI) 6,418
Not applicableStudy completedNCT06736353
What this trial is testing

Effect of Classic Secondary Prevention in Type 2 MI: A Target Trial Emulation Study

Who this might be right for
Myocardial Infarction Type 2
Uppsala University 14,000
Not applicableStudy completedNCT02768935
What this trial is testing

Macrophage Phenotype in Type 2 Diabetics After Myocardial Infarction and the Potential Role of miRNAs Secreted

Who this might be right for
DIABETESMYOCARD INFARCTUS
Centre Hospitalier Universitaire de Nice 20
Large-scale testing (Phase 3)Study completedNCT00968708
What this trial is testing

Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Who this might be right for
Diabetes Mellitus, Type 2Acute Coronary Syndrome
Takeda 5,380
Not applicableStudy completedNCT03939624
What this trial is testing

Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and Risk of Cardiovascular Events

Who this might be right for
Type2 DiabetesMyocardial InfarctionIschemic Stroke+3 more
Canadian Network for Observational Drug Effect Studies, CNODES 419,734
Load More Results